Pharmacological or genetic inhibition of TLR4/NF-κB signaling can reduce microglial activation and neuronal apoptosis (Tan et al., 2018), but its contribution to sevoflurane-induced cognitive deficits has not been determined. This evidence concerns the gene TLR4 and Cognitive impairment.